Works matching AU Stingl, Julia Carolin

Results: 13

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes.

Published in:

Pharmaceutics, 2022, v. 14, n. 12, p. 2833, doi. 10.3390/pharmaceutics14122833

By:

Stingl, Julia Carolin;
Radermacher, Jason;
Wozniak, Justyna;
Viviani, Roberto

Publication type:

Article

Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.

Published in:

PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230632

By:

Dubrall, Diana;
Schmid, Matthias;
Stingl, Julia Carolin;
Sachs, Bernhardt

Publication type:

Article

Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.

Published in:

Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-00900-8

By:

Barakat, Abdul Karim;
Scholl, Catharina;
Steffens, Michael;
Brandenburg, Kerstin;
Ising, Marcus;
Lucae, Susanne;
Holsboer, Florian;
Laje, Gonzalo;
Kalayda, Ganna V.;
Jaehde, Ulrich;
Stingl, Julia Carolin

Publication type:

Article

Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.

Published in:

Drugs & Aging, 2018, v. 35, n. 6, p. 559, doi. 10.1007/s40266-018-0550-6

By:

Schneider, Katharina Luise;
Kastenmüller, Kathrin;
Weckbecker, Klaus;
Bleckwenn, Markus;
Böhme, Miriam;
Stingl, Julia Carolin

Publication type:

Article

Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2019.01620

By:

Schneider, Katharina Luise;
Kunst, Melanie;
Leuchs, Ann-Kristin;
Böhme, Miriam;
Weckbecker, Klaus;
Kastenmüller, Kathrin;
Bleckwenn, Markus;
Holdenrieder, Stefan;
Coch, Christoph;
Hartmann, Gunther;
Stingl, Julia Carolin

Publication type:

Article

Identification and comparison of sex‐specific serious adverse drug reactions in spontaneous reports and systematically collected reports (ADRED).

Published in:

British Journal of Clinical Pharmacology, 2024, v. 90, n. 3, p. 776, doi. 10.1111/bcp.15941

By:

Christ, Patrick;
Dubrall, Diana;
Just, Katja Susanne;
Lewke, Britta;
Below, Maike;
Stingl, Julia Carolin;
Schmid, Matthias;
Sachs, Bernhardt

Publication type:

Article

Population nutrikinetics of green tea extract.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193074

By:

Scholl, Catharina;
Lepper, Anna;
Lehr, Thorsten;
Hanke, Nina;
Schneider, Katharina Luise;
Brockmöller, Jürgen;
Seufferlein, Thomas;
Stingl, Julia Carolin

Publication type:

Article

Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.

Published in:

BMC Family Practice, 2016, v. 17, p. 1, doi. 10.1186/s12875-016-0447-6

By:

Stingl, Julia Carolin;
Kaumanns, Katharina Luise;
Claus, Katrin;
Lehmann, Marie-Louise;
Kastenmüller, Kathrin;
Bleckwenn, Markus;
Hartmann, Gunther;
Steffens, Michael;
Wirtz, Dorothee;
Leuchs, Ann-Kristin;
Benda, Norbert;
Meier, Florian;
Schöffski, Oliver;
Holdenrieder, Stefan;
Coch, Christoph;
Weckbecker, Klaus

Publication type:

Article

Impact of steroid hormone levels on estradiol‐mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 4, p. 429, doi. 10.1111/bcpt.14069

By:

Hoffmann, Marco;
Müller, Julian Peter;
Maurer, Jochen;
Folliot, Anne‐Marie;
Yamoune, Sabrina;
Stingl, Julia Carolin

Publication type:

Article

Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.

Published in:

2010

By:

Stingl, Julia Carolin;
Parmar, Sumit;
Huber-Wechselberger, Ariana;
Kainz, Alexander;
Renner, Wilfried;
Seeringer, Angela;
Brockmöller, Jürgen;
Langsenlehner, Uwe;
Krippl, Peter;
Haschke-Becher, Elisabeth

Publication type:

Journal Article

Impact of UGT2B7 <sup>His268Tyr</sup> polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Published in:

Breast Cancer Research, 2011, v. 13, n. 3, p. 1, doi. 10.1186/bcr2894

By:

Parmar, Sumit;
Stingl, Julia Carolin;
Huber-Wechselberger, Ariana;
Kainz, Alexander;
Renner, Wilfried;
Langsenlehner, Uwe;
Krippl, Peter;
Brockmöller, Jürgen;
Haschke-Becher, Elisabeth

Publication type:

Article

Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Published in:

2011

By:

Parmar, Sumit;
Stingl, Julia Carolin;
Huber-Wechselberger, Ariana;
Kainz, Alexander;
Renner, Wilfried;
Langsenlehner, Uwe;
Krippl, Peter;
Brockmöller, Jürgen;
Haschke-Becher, Elisabeth

Publication type:

journal article

Pharmacogenetic guided drug therapy – how to deal with phenoconversion in polypharmacy.

Published in:

2025

By:

Stingl, Julia Carolin;
Viviani, Roberto

Publication type:

Report